Children's Medical Center Dallas
Locations
Transplant Summary
Overview
Our program offers pediatric and adolescent transplant services using related/unrelated donor stem cells and cord blood. Services include pre-transplant assessment, compatibility testing of donor/recipient, psychosocial assistance, extensive education and comprehensive post-transplant follow-up care.This center has been performing allogeneic transplants since 1992 and has been an NMDP transplant center since April 2002.
Attending physicians
Adult - Victor Aquino, Margaret Boyden, Erin Butler, Kathryn Dickerson, Jessica Garcia, Samuel John, Andy Koh, An Pham, Ksenya Shliakhtsitsava, Tiffany Simms-Waldrip, Jamie Truscott, Tanya Watt, Sisi Zhang, Ayesha Zia
Pediatric - Victor Aquino, Margaret Boyden, Erin Butler, Kathryn Dickerson, Jessica Garcia, Samuel John, Andy Koh, An Pham, Ksenya Shliakhtsitsava, Tiffany Simms-Waldrip, Jamie Truscott, Tanya Watt, Sisi Zhang, Ayesha ZiaTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Pediatric onlyOther programs and services
Our program offers pediatric and adolescent transplant services using related/unrelated donor stem cells and cord blood. Services include pre-transplant assessment, compatibility testing of donor/recipient, psychosocial assistance, extensive education, and comprehensive post-transplant follow-up care. Lodging accommodations are available at the Ronald McDonald House. Our Social Work team also works with families to assist with arrangements for travel and lodging.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 63 patients.The actual 1-year survival of these patients is 87.1%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 79% and 94.7%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total pediatric transplants
89
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow17PBSC6Cord blood0Total23Unrelated donorMarrow16PBSC5Cord blood4Total25Total allogeneicMarrow33PBSC11Cord blood4Total48AutologousMarrowBoth marrow & PBSC 41PBSC—Cord blood—Total41Total combinedMarrowBoth marrow & PBSC 85PBSC—Cord blood4Total89Total adult transplants
8
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow2PBSC3Cord blood0Total5Unrelated donorMarrow2PBSC0Cord blood0Total2Total allogeneicMarrow4PBSC3Cord blood0Total7AutologousMarrowBoth marrow & PBSC 1PBSC—Cord blood—Total1Total combinedMarrowBoth marrow & PBSC 8PBSC—Cord blood0Total8All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-182719-44145-64065+0Total28Unrelated 0-182719-44045-64065+0Total27Autologous 0-184119-44145-64065+0Total42Total 0-189519-44245-64065+0Total97Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorKatherine SmallingPhone: (214) 456-8905Financial representativeKristina GonzalezPhone: (214) 456-5642NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Children's Medical Center Dallas - ACE Program
1935 Medical District Dr. Dallas, TX 75235 Phone:214-456-2978 For more information about this program: https://www.childrens.com/specialties-services/specialty-centers-and-programs/cancer-and-blood-disorders/programs-and-services/oncology/cancer-survivors (Opens in a new tab)Overview
The ACE Program at Children's Health and UT Southwestern Medical Center was established in 1989 and is the first and largest childhood cancer survivors program in North Texas. The ACE Program evaluates and monitors childhood cancer survivors from ages 4 to 62 years old. Objectives of the ACE program include patient and physician education, patient care, and clinical research in the late effects of cancer survivors. The ACE Program is a member of the Childhood Cancer Survivors Study (CCSS), the leading consortium in late effects research. Numerous studies from the CCSS have determined the frequency of late effects and identified risk factors for late effects in this childhood cancer survivors.
Staff
Program Director:Dan Bowers, MDProgram Coordinator:Cynthia Cochran, PNPMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Children- Allogeneic and Autologous transplant recipients
- 3 years after transplant.
- Patients who were transplanted as a child at this center up to age 21
- Does accept patients who were transplanted at another hospital
- Will admit pediatric patients who transferred into the program if they are under age 21